Lyophilized Plasma for Resuscitation in a Swine Model of Severe Injury | Bleeding and Transfusion | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Asensio  JTrunkey  D Prehospital fluid resuscitation: what type, how much, and controversies.  Current Therapy of Trauma and Surgical Critical Care. Philadelphia, PA CV Mosby2008;32Google Scholar
2.
Borgman  MASpinella  PPerkins  J  et al.  The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital.  J Trauma 2007;63 (4) 805- 813PubMedGoogle Scholar
3.
Cotton  BAAu  BNunez  TGunter  OLRobertson  AMYoung  PP Predefined massive transfusion protocols are associated with a reduction in organ failure and postinjury complications.  J Trauma 2009;66 (1) 41- 49PubMedGoogle Scholar
4.
Cotton  BAGunter  OLIsbell  J  et al.  Damage control hematology.  J Trauma 2008;64 (5) 1177- 1183PubMedGoogle Scholar
5.
Holcomb  JBWade  CEMichalek  JE  et al.  Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients.  Ann Surg 2008;248 (3) 447- 458PubMedGoogle Scholar
6.
Duchesne  JCHunt  JPWahl  G  et al.  Review of current blood transfusions strategies in a mature level I trauma center.  J Trauma 2008;65 (2) 272- 278PubMedGoogle Scholar
7.
Gunter  OL  JrAu  BKIsbell  JMMowery  NTYoung  PPCotton  BA Optimizing outcomes in damage control resuscitation.  J Trauma 2008;65 (3) 527- 534PubMedGoogle Scholar
8.
Sperry  JLOchoa  JGunn  S  et al. Inflammation the Host Response to Injury Investigators, An FFP:PRBC transfusion ratio ≥1:1.5 is associated with a lower risk of mortality after massive transfusion.  J Trauma 2008;65 (5) 986- 993PubMedGoogle Scholar
9.
Huber-Wagner  SQvick  MMussack  T  et al. Working Group on Polytrauma of German Trauma Society (DGU), Massive blood transfusion and outcome in 1062 polytrauma patients.  Vox Sang 2007;92 (1) 69- 78PubMedGoogle Scholar
10.
Maegele  MLefering  RPaffrath  TTjardes  TSimanski  CBouillon  BWorking Group on Polytrauma of the German Society of Trauma Surgery (DGU), Red blood cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury.  Vox Sang 2008;95 (2) 112- 119PubMedGoogle Scholar
11.
Kashuk  JLMoore  EJohnson  J  et al.  Postinjury life threatening coagulopathy.  J Trauma 2008;65 (2) 261- 271PubMedGoogle Scholar
12.
Shuja  FShults  CDuggan  M  et al.  Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy.  J Trauma 2008;65 (5) 975- 985PubMedGoogle Scholar
13.
Cho  SDHolcomb  JTieu  B  et al.  Reproducibility of an animal model simulating complex combat-related injury in a multiple-institution format.  Shock 2009;31 (1) 87- 96PubMedGoogle Scholar
14.
Heiden  MSeitz  R Quality of therapeutic plasma—requirements for marketing authorization.  Thromb Res 2002;107 ((suppl 1)) S47- S51PubMedGoogle Scholar
15.
Hellstern  PHaubelt  H Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy.  Thromb Res 2002;107 ((suppl 1)) S3- S8PubMedGoogle Scholar
16.
Visser  TPillay  JKoenderman  LLeenen  LP Postinjury immune monitoring: can multiple organ failure be predicted?  Curr Opin Crit Care 2008;14 (6) 666- 672PubMedGoogle Scholar
17.
Arnold  RCShapiro  NIJones  AE  et al. Emergency Medicine Shock Research Network (EMShockNet) Investigators, Multi-center study of early lactate clearance as a determinant of survival in patients with presumed sepsis.  Shock 2009;32 (1) 35- 39PubMedGoogle Scholar
18.
Nast-Kolb  DWaydhas  CGippner-Steppert  C  et al.  Indicators of the posttraumatic inflammatory response correlate with organ failure in patients with multiple injuries.  J Trauma 1997;42 (3) 446- 455PubMedGoogle Scholar
19.
Martin  CBoisson  CHaccoun  MThomachot  LMege  JL Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.  Crit Care Med 1997;25 (11) 1813- 1819PubMedGoogle Scholar
20.
Giannoudis  PVHarwood  PJLoughenbury  PVan Griensven  MKrettek  CPape  HC Correlation between IL-6 levels and the systemic inflammatory response score: can an IL-6 cutoff predict a SIRS state?  J Trauma 2008;65 (3) 646- 652PubMedGoogle Scholar
21.
Gebhard  FPfetsch  HSteinbach  GStrecker  WKinzl  LBrückner  UB Is interleukin 6 an early marker of injury severity following major trauma in humans?  Arch Surg 2000;135 (3) 291- 295PubMedGoogle Scholar
22.
Ozturk  HYagmur  YOzturk  H The prognostic importance of serum IL-1β, IL-6, IL-8, and TNF-α levels compared to trauma scoring systems for early mortality in children with blunt trauma.  Pediatr Surg Int 2008;24 (2) 235- 239PubMedGoogle Scholar
23.
Kobbe  PVodovotz  YKaczorowski  DMollen  KPBilliar  TRPape  HC Patterns of cytokine release and evolution of remote organ dysfunction after bilateral femur fracture.  Shock 2008;30 (1) 43- 47PubMedGoogle Scholar
24.
Seekamp  AJochum  MZiegler  Mvan Griensven  MMartin  MRegel  G Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion.  J Trauma 1998;44 (5) 874- 882PubMedGoogle Scholar
25.
Long  CLMaull  KIKrishnan  RS  et al.  Ascorbic acid dynamics in the seriously ill and injured.  J Surg Res 2003;109 (2) 144- 148PubMedGoogle Scholar
26.
Berger  MMSoguel  LShenkin  A  et al.  Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients [published online August 2008].  Crit Care 2008;12 (4) R101PubMed10.1186/cc6981Google Scholar
27.
Heyland  DKDhaliwal  RSuchner  UBerger  MM Antioxidant nutrients.  Intensive Care Med 2005;31 (3) 327- 337PubMedGoogle Scholar
28.
Collier  BRGiladi  ADossett  LADyer  LFleming  SBCotton  BA Impact of high-dose antioxidants on outcomes in acutely injured patients.  JPEN J Parenter Enteral Nutr 2008;32 (4) 384- 388PubMedGoogle Scholar
29.
Nathens  ABNeff  MJurkovich  G  et al.  Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients.  Ann Surg 2002;236 (6) 814- 822PubMedGoogle Scholar
30.
Dichtelmüller  HOBiesert  LFabbrizzi  F  et al.  Robustness of solvent/detergent treatment of plasma derivatives [published online May 20, 2009].  Transfusion PubMed10.1111/j.1537-2995.2009.02222.xGoogle Scholar
31.
Champion  HR Combat fluid resuscitation: introduction and overview of conferences.  J Trauma 2003;54 (5) ((suppl)) S7- S12PubMedGoogle Scholar
Paper
September 21, 2009

Lyophilized Plasma for Resuscitation in a Swine Model of Severe Injury

Author Affiliations

Author Affiliations: Division of Trauma and Critical Care, Oregon Health and Science University, Portland (Drs Spoerke, Zink, Cho, Karahan, and Schreiber and Messrs Differding and Muller); Office of the Director of Combat Casualty Care Research, US Army Institute of Surgical Research, San Antonio, Texas (Dr Sondeen); and Division of Acute Care Surgery, The University of Texas at Houston (Dr Holcomb).

Arch Surg. 2009;144(9):829-834. doi:10.1001/archsurg.2009.154
Abstract

Hypothesis  Lyophilized plasma (LP) is as safe and effective as fresh frozen plasma (FFP) for resuscitation after severe trauma.

Design  Multicenter animal study.

Setting  Animal laboratories, 2 level I trauma centers.

Participants  Thirty-two Yorkshire crossbred swine.

Interventions  Lyophilized plasma was analyzed for factor levels and clotting activity before lyophilization and after reconstitution. Swine were subjected to complex multiple trauma including extremity fracture, hemorrhage, severe liver injury, acidosis, and hypothermia. They were then resuscitated with FFP, LP, FFP and packed red blood cells (PRBCs) in a ratio of 1:1, or 1:1 LP and PRBCs.

Main Outcome Measures  Residual clotting activity of LP after reconstitution, swine mortality, hemodynamic measures, total blood loss, coagulation profiles, and inflammatory measures.

Results  Lyophilization decreased clotting factor activity by an average of 14%. Survival and heart rate were similar between all groups. Swine resuscitated with LP had equivalent or higher mean arterial pressures. Swine treated with LP had similar coagulation profiles, plasma lactate levels, and postinjury blood loss compared with those treated with FFP. Swine treated with 1:1 FFP-PRBCs were similar to those treated with 1:1 LP-PRBCs. Resuscitation with LP resulted in a reduction in postresuscitation interleukin 6 expression compared with resuscitation with FFP.

Conclusions  The process of lyophilization and reconstitution of plasma reduces coagulation factor activity by 14%, without acute differences in blood loss. Lyophilized plasma can be used for resuscitation in a severe multiple trauma and hemorrhagic shock swine model with efficacy equal to that of FFP and with decreased interleukin 6 production.

×